ABBOTT PARK, Ill., May 16 Abbott today announcedthe launch of the StarClose(R) SE Vascular Closure System, a next-generationvessel closure device engineered to enable fast, safe and secure closure ...

ABBOTT PARK, IL — Abbott Vascular is voluntarily recalling lots of its StarClose SE vascular system because of difficulty or failure to deploy its clip, according to the device manufacturer [1]. The ...

Abbott declared the 371st consecutive quarterly dividend of 26 cents per share on Sept. 15. The current dividend yield is 2.60%. The company is a long-term dividend payer and has increased its ...

Abbott Park, IL - The US Food and Drug Administration has approved the StarClose vascular closure system (Abbott), used for femoral-artery closure following diagnostic catheterization procedures, the ...

ABBOTT PARK, Ill., Dec. 22 (UPI) -- Abbott Laboratories said Thursday it has been cleared to market its StarClose Vascular Closure System. The company said the Food and Drug Administration has ...

En route to Abbott’s acquisition of St. Jude Medical, the duo is agreeing to sell off portions of their vascular and electrophysiology units, worth about $1.12 billion, to Terumo. The transaction is ...

-- Improved ease of use, with an intuitive, numbered system, providing visual guidance and audible "clicks" for each step leading to clip deployment -- Immediate vessel closure with deployment of a ...

-- New Device Designed to Provide Fast, Safe and Secure Vessel Closure Following Catheterization Procedures Abbott today announced the launch of the StarClose(R) SE Vascular Closure System, a ...